Menopause: The Hormones That Protect You

To understand menopause, you first need to understand what you are losing.

During a normal menstrual cycle, Oestradiol (the primary oestrogen), Progesterone, and Testosterone rise and fall in a carefully orchestrated pattern. In the follicular phase (days 1-14), oestradiol climbs steadily, peaking just before ovulation. This surge triggers the release of an egg and drives a brief spike in LH (luteinising hormone). After ovulation, the corpus luteum produces progesterone, which dominates the luteal phase (days 15-28), preparing the uterine lining and stabilising mood. Testosterone fluctuates more subtly, peaking around ovulation to support libido and energy.

This is not just a reproductive process. Every one of these hormonal shifts has systemic effects on your brain, bones, cardiovascular system, immune function, and metabolism. The monthly cycle is your body's way of maintaining a hormonal environment that protects virtually every organ system. When that cycle becomes erratic and eventually stops, the consequences extend far beyond fertility.

The conversation around female hormones is dominated by reproduction. That framing dramatically undersells their importance.

Oestradiol is a powerhouse. It maintains bone mineral density by inhibiting osteoclast activity (the cells that break down bone). It is directly cardioprotective: it promotes healthy endothelial function, improves lipid profiles by raising HDL and lowering LDL, and helps regulate blood pressure. It supports skin elasticity, joint lubrication, and bladder function. In the brain, oestradiol enhances serotonin and dopamine activity, supporting mood, memory, concentration, and sleep quality. It is neuroprotective, and declining levels are associated with increased risk of cognitive decline and dementia.

Progesterone is far more than a pregnancy hormone. It has potent calming effects on the central nervous system through its conversion to allopregnanolone, a neurosteroid that modulates GABA receptors. This is why progesterone is critical for sleep quality and anxiety regulation. It also has anti-inflammatory properties and plays a role in maintaining healthy thyroid function.

Testosterone in women is essential for energy, motivation, muscle maintenance, bone density, and libido. Women produce testosterone throughout their lives (primarily from the ovaries and adrenal glands), and it declines gradually from the late twenties onwards. By the time menopause arrives, levels may be a fraction of what they were at peak, with significant consequences for quality of life.

The symptoms of declining oestrogen are well known: hot flushes, night sweats, vaginal dryness, and irregular periods. But the less visible effects are often more damaging in the long run.

Low Oestradiol accelerates bone loss, increasing fracture risk dramatically. Cardiovascular risk rises sharply after menopause as the protective effects on blood vessels and lipids diminish. Cognitive symptoms including brain fog, difficulty concentrating, and memory lapses are commonly reported and increasingly linked to oestrogen withdrawal in the brain. Joint pain, dry skin, recurrent urinary tract infections, and low mood are all consequences of oestrogen deficiency that are frequently dismissed or misdiagnosed.

Low Progesterone manifests as anxiety, insomnia, irritability, and a sense of inner restlessness that many women describe as feeling "wired but tired". During perimenopause, progesterone often drops before oestrogen does, which is why sleep disturbance and anxiety frequently appear as the earliest symptoms, sometimes years before periods stop.

Low Testosterone causes persistent fatigue, loss of motivation, reduced muscle mass, weight gain (particularly around the abdomen), and a significant decline in libido. These symptoms are routinely attributed to "just getting older" or stress, but they are measurable hormonal deficiencies with treatable causes.

The risks of sustained deficiency are not trivial. Osteoporosis, cardiovascular disease, type 2 diabetes, depression, and cognitive decline are all significantly more prevalent in women with untreated hormonal deficiency following menopause.

The British Menopause Society (BMS) currently advises that menopause is a clinical diagnosis based on symptoms, and that hormone testing is "not usually necessary" for women over 45. This position is well-intentioned but increasingly out of step with modern practice.

The rationale for not testing is that hormone levels fluctuate during perimenopause, making single readings potentially misleading. That is a valid observation, but it is an argument for better testing protocols, not for no testing at all.

Measuring Oestradiol, FSH, LH, Progesterone, and Testosterone provides objective data that symptoms alone cannot. Two women with identical symptoms may have very different hormonal profiles, and those differences have implications for treatment decisions, monitoring, and risk assessment. A woman with vasomotor symptoms and an oestradiol level of 80 pmol/L is in a different clinical situation from one with a level of 15 pmol/L, even if both are symptomatic.

For women on HRT, blood testing is the only reliable way to confirm that replacement is achieving adequate physiological levels. Dosing based purely on symptom response risks under-replacement (leaving you unprotected) or over-replacement. Testosterone supplementation in particular requires monitoring, as there are no subjective symptoms that reliably correlate with specific blood levels.

Testing also provides a baseline. If you measure your hormones at 40, you have a reference point against which to track change. If you wait until symptoms are severe at 52, you have no idea how far you have fallen or how quickly.

One of the most common mistakes in menopause management is assuming that every symptom is hormonal. Many are, but not all, and missing a non-hormonal cause can delay treatment and cause unnecessary suffering.

Thyroid Function is the most important differential. Hypothyroidism causes fatigue, weight gain, brain fog, depression, dry skin, hair thinning, and menstrual irregularity. Every one of these overlaps with perimenopause. Thyroid dysfunction is significantly more common in women, and its prevalence increases with age, peaking in the same decade that menopause typically occurs. Testing TSH, Free T4, and Free T3 should be standard practice for any woman presenting with these symptoms.

Ferritin and Full Blood Count rule out iron deficiency anaemia, another extremely common cause of fatigue, breathlessness, poor concentration, and low mood in women. Heavy or prolonged periods during perimenopause can deplete iron stores rapidly, and the resulting anaemia is often attributed to hormonal changes when it is actually a separate, treatable condition.

Vitamin D deficiency causes fatigue, muscle pain, joint stiffness, and low mood. It is widespread in the UK population and worsens bone health at a time when oestrogen decline is already accelerating bone loss.

HbA1c and Insulin assess metabolic health. Insulin resistance becomes more common as oestrogen declines, and catching it early allows dietary and lifestyle intervention before it progresses to type 2 diabetes.

Vitamin B12 deficiency causes neurological symptoms (tingling, numbness, balance issues) and cognitive impairment that can mimic or compound menopausal brain fog.

A comprehensive blood panel does not replace a hormone assessment. It complements it, ensuring that treatable conditions are not hidden behind a blanket menopause diagnosis.

Menopause is not a disease. It is a natural transition. But the hormonal changes it brings carry genuine, measurable health risks that increase with every year of untreated deficiency.

Bone density declines by up to 20% in the first five to seven years after menopause. By the time osteoporosis is diagnosed on a DEXA scan, significant irreversible loss has already occurred. Cardiovascular disease risk doubles within a decade of menopause. The "protection gap" that opens when oestrogen declines is well documented in epidemiological data, and it is the primary reason women's heart disease risk catches up with men's in the post-menopausal years.

The psychological toll is equally significant. Depression, anxiety, loss of identity, relationship strain, and reduced quality of life are reported by the majority of women going through menopause. These are not inevitable consequences of ageing. They are, in large part, consequences of hormonal deficiency that can be measured, monitored, and addressed.

Knowledge is the starting point. You cannot make informed decisions about HRT, supplements, lifestyle changes, or simply understanding what is happening to your body without data. Blood testing gives you that data, and it gives you the power to take control of a process that too many women are still told to simply endure.